Biocon Limited has informed the Exchange about Qualified Institutions Placement of equity shares
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Biocon Limited has opened its Qualified Institutions Placement (QIP) of equity shares with a face value of ₹5 each on June 16, 2025. The Fund Raising Committee has set the floor price at ₹340.20 per share, based on the SEBI pricing formula. The company retains the discretion to offer a discount of up to 5% on this floor price. The final issue price will be determined in consultation with the Book Running Lead Managers based on investor demand. The QIP was previously approved by the Board on April 23, 2025, and by shareholders through a postal ballot on June 4, 2025. The trading window for insiders has been closed until further notice.
The QIP will result in dilution of existing shareholders' stakes but will strengthen the company's capital base for growth, debt reduction, or strategic initiatives. The floor price of ₹340.20 sets a benchmark — the actual issue price will depend on institutional demand and could be at a premium or discount to this level.